You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

July 20, 2018

PLC Distribution and Marketing of Drugs 2018 – Vietnam Chapter

Subscribe to Updates
Practical Law Company

Practical Law has published the 2018 edition of its Distribution and Marketing of Drugs Global Guide, a easily accessible Q&A overview of the key legal issues involved in bringing drugs to market in 29 jurisdictions worldwide. Members of the Tilleke & Gibbins life sciences team wrote the Vietnam chapter of this year’s guide.

The Vietnam chapter provides a high-level overview of the regulatory regime for the distribution and marketing of pharmaceuticals in Vietnam. The distribution section of the guide covers pre-conditions for distribution, including marketing authorization and exceptions; licensing; distribution to consumers; and wholesale distribution. The marketing section summarizes the regulations on marketing to consumers and marketing to professionals, including the types of marketing activities that are permitted and prohibited; restrictions on advertising; and the permissibility of discounts, free samples, and sponsorships.

Tilleke & Gibbins also contributed the Thailand chapter of the guide. To read the Vietnam chapter, please click on the link below.

Download Full Article
Related Professionals

Industries

Life Sciences

Practices

Corporate/M&A

Intellectual Property

Regulatory Affairs

Location

RELATED INSIGHTS​ 

May 3, 2011
In Thailand, the importation, manufacture, and sale of medicine is governed by the Medicine Act B.E. 2510 (1967). The Act also stipulates the requirements/procedures to apply for a license to import, manufacture, or sell medicine and the duties and obligations with which such license holder must comply. This article provides an overview of the requirements.
Read More
May 3, 2011
Written in a Q&A format, this chapter provides a comprehensive overview of the issues faced by life sciences companies in Thailand. Topics covered include the regulatory framework, manufacturing of medicinal products, clinical trials, marketing restrictions, packaging and labeling requirements, intellectual property issues, and product liability.
Read More
May 3, 2011
Before being marketed in Thailand, a wide variety of products must be registered at the Thai Food and Drug Administration (FDA). These products range from food, food supplements, beverages and medical devices to animal health products, cosmetics, hazardous substances, and all types of pharmaceuticals. Due to the large number of product applications that are filed at the Thai FDA and the stringency of registration requirements, registration timelines—particularly for pharmaceutical products—can be very long.
Read More
April 30, 2011
In recent years, Thailand has seen an increasing number of pharmaceutical patent litigations, launched by drug originators to combat infringing generic products in the market. This article looks at the forces underlying this trend and recommends several legal options to allow drug originators to defend their products against low-price infringing generics.
Read More